Advantages of prophylactic versus conventionally scheduled heart failure treatment in doxorubicin induced cardiomyopathy
28 May 2018 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
University of Debrecen, Debrecen (Hungary)
28 More presentations in this session
Access the full session
The Event
Heart Failure 2018
28 May 2018
08:30 CET
You may be interested in
Congress Session
/f/125658/640x360/fe5123d923/ett-s3-ep15.png)
Congress Session
